Diaceutics PLC announced revenue results for the six months ended 30 June 2023. For the period, the company reported revenue grew 32% to £9.9 million in against £7.5 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
115.8 GBX | +5.27% | +21.24% | +34.48% |
May. 16 | EARNINGS AND TRADING: Michelmersh continues with positive order intake | AN |
May. 16 | Diaceutics Bags Two Enterprise-wide Engagements with Large Pharmaceutical Companies | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.48% | 118M | |
+20.32% | 4.61B | |
-17.33% | 2.34B | |
+24.85% | 1.93B | |
-9.90% | 1.59B | |
-0.99% | 1.56B | |
-22.35% | 1.48B | |
-33.12% | 1.24B | |
-9.23% | 1.15B | |
-13.15% | 956M |
- Stock Market
- Equities
- DXRX Stock
- News Diaceutics PLC
- Diaceutics PLC Announces Revenue Results for the Six Months Ended 30 June 2023